文献速递瓣膜病与结构性心脏病

COVID-19大流行后心脏瓣膜病的门诊管理:对当前和未来医疗的启示

Outpatient management of heart valve disease following the COVID-19 pandemic: implications for present and future care.
PubMed 文献 · Heart · 2020-08-31

本文针对COVID-19大流行对心脏瓣膜病患者门诊监测、新杂音患者超声心动图检查及重症患者手术/经导管治疗及时性造成的冲击,提出门诊服务重构方法,并给出当前随访频率和超声心动图使用的建议。强调应优先处理临床需求最大的患者(如有症状的重症HVD),并建议发展和评估虚拟门诊等新型工作模式。

要点

  • 大流行造成HVD门诊监测与治疗延迟,积压和疾病升级增加风险与成本。
  • 应优先处理有症状的重症HVD患者,并考虑当地手术等待时间选择干预方式。
  • 可安全推迟稳定HVD患者的随访,并在适当分诊下让部分患者出院。

核心结论

  • 大流行后几乎不可能完全恢复疫情前的HVD门诊实践,必须优先处理临床需求最大的患者,并发展和评估虚拟门诊等新模式。

研究设计与样本

  • 本文为针对COVID-19大流行后心脏瓣膜病门诊管理的建议性文章,提出了服务重构方法和随访/超声心动图使用建议。

主要发现

  • 大流行显著影响了HVD门诊安全监测、新杂音患者的超声心动图检查以及重症患者手术或经导管治疗的及时性。
  • 上述影响造成了大量工作积压和疾病升级,导致治疗风险和成本增加,并可能使长期结局更差。

关键数值与推荐

  • 应优先处理临床需求最大的患者,如有症状的重症HVD患者。
  • 在决定需要干预的患者接受外科手术还是经导管治疗时,除常规临床特征外,还需考虑当地手术等待时间。
  • 本文提出了识别可安全推迟随访的稳定HVD患者的方法,并建议在适当临床输入下对等待名单进行分诊,部分患者可出院。

临床怎么用

  • 优先安排有症状的重症HVD患者进行评估和干预。
  • 根据当地手术等待时间和临床特征,为需要干预的患者选择外科手术或经导管治疗。
  • 识别稳定HVD患者,安全推迟随访;在适当分诊下可让部分患者出院。
  • 进一步发展和评估虚拟门诊等新型工作模式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The established processes for ensuring safe outpatient surveillance of patients with known heart valve disease (HVD), echocardiography for patients referred with new murmurs and timely delivery of surgical or transcatheter treatment for patients with severe disease have all been significantly impacted by the novel coronavirus pandemic. This has created a large backlog of work and upstaging of disease with consequent increases in risk and cost of treatment and potential for worse long-term outcomes. As countries emerge from lockdown but with COVID-19 endemic in society, precautions remain that restrict 'normal' practice. In this article, we propose a methodology for restructuring services for patients with HVD and provide recommendations pertaining to frequency of follow-up and use of echocardiography at present. It will be almost impossible to practice exactly as we did prior to the pandemic; thus, it is essential to prioritise patients with the greatest clinical need, such as those with symptomatic severe HVD. Local procedural waiting times will need to be considered, in addition to usual clinical characteristics in determining whether patients requiring intervention would be better suited having surgical or transcatheter treatment. We present guidance on the identification of stable patients with HVD that could have follow-up deferred safely and suggest certain patients that could be discharged from follow-up if waiting lists are triaged with appropriate clinical input. Finally, we propose that novel models of working enforced by the pandemic-such as increased use of virtual clinics-should be further developed and evaluated.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Shah BN, Schlosshan D, McConkey HZR, et al. Outpatient management of heart valve disease following the COVID-19 pandemic: implications for present and future care. Heart. 2020. PMID: 32868279. doi:10.1136/heartjnl-2020-317600

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。